UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): October 2, 1997
---------------
ARTAGRAPH REPRODUCTION TECHNOLOGY INCORPORATED
- --------------------------------------------------------------------------------
(Exact name of Registrant specified in its charter)
Ontario, Canada 0-16008 98-0082514
- --------------------------------------------------------------------------------
(State or other (Commission File (I.R.S. Employer
jurisdiction or incorporation) (Number I.D. Number)
5-7100 Warden Avenue, Markham, Ontario, L3R 5M7 Canada
- --------------------------------------------------------------------------------
(Address of Principal Offices Including Zip Code)
(905) 477-0252
- --------------------------------------------------------------------------------
(Registrant's Telephone Number)
<PAGE>
ITEM 5. OTHER EVENTS
Pursuant to a meeting of the Board of Directors of Artagraph Reproduction
Technology Incorporated (the Company) offered in a private placement transaction
exempt from registration under Regulation S a total of 500 Units, each unit
consisting of 1,000,000 shares of the Company's common stock at an offering
price of $1,000 per unit.
The sale of the first Unit took place on October 2, 1997.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities and
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
ARTAGRAPH REPRODUCTION TECHNOLOGY INCORPORATED
/s/ Simon P. Meredith
- -------------------------
BY: Simon P. Meredith
President, Chief Operating Officer
and Director
